Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional)
Due: Mar 14, 2024
There are gaps that prevent the utilization of decentralized clinical trials (DCT) in substance use area. The existing sensors for physiological measurement are rarely used and may need further validation. There are no wearable or home-use detection devices on the market capable to measure substances of interest (e.g., methadone, buprenorphine, their metabolites, as well as the spectrum of illicit drugs). The devices in development are not intended for diagnostics or treatment. Most of the devices are intended for laboratory use....
Additional Eligibility Information
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Category of Funding Activity
Grantor Contact Information
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Other Grantor Informaiton
NIH Grants Information firstname.lastname@example.org